Articles by CeMi Team

New Research Incentive Grant for Hannah Donnelly!

Congratulations to Hannah Donnelly, a PDRA with Prof Matt Dalby at the Centre for the Cellular Microenvironment, was this month awarded a Research Incentive Grant (RIG) from The Carnegie Trust. RIGs are an excellent opportunity for early career researchers to undertake, as the Principle Investigator, a short research project. This project can be stand-alone in

#Run2Jordan

University of Glasgow and Strathclyde are coming together, taking part in the biggest CeMi fitness challenge to date! For the last three months we have participated in a series of challenges, from personal fitness goals to cooking challenges, we have passed our £500 target to help support the amazing work of the Sir Bobby Charlton

HEALIKICK logo competition

HEALIKICK – logo design brief Competition details To create a logo for the HEALIKICK project. The chosen logo will be used on communication and dissemination materials throughout the project. Logo entries to the competition should be emailed to HEALIKICK Admin (healikick-admin@glasgow.ac.uk) by 3rd July 2020. Entries should be sent in PDF format, but the winning

Sir Bobby Charlton Strategic Board Meeting, 04/03/2020

On Wednesday 4th March we held the annual Sir Bobby Charlton Foundation Annual Strategic Board meeting. Jane Bateman, a member of the SBCF board, was in attendance. Professor Manuel Salmeron-Sanchez & Matt Dalby, Principal Investigators, welcome all members of the team and particularly Jane Bateman, a new member of the SBCF board, who joined the

GLORI 2020 Symposium

On Wednesday 19th February, the Glasgow Orthopaedic Research Initiative held it’s 8th symposium, bringing together expertise from the fields of orthopaedics, plastic surgery, biology, engineering and chemistry. The event was held in the Debates Chamber of the Glasgow University Student Union and with 90 registered attendees, the day was an exciting one! Professor Dominic Meek

Vacancy: Research Assistant & PhD Student

Pathological conditions, including non-union bone defects, skin lesions, neurological disorders and inflammatory processes during cancer development are growing in occurrence due to an aging population. These problems are debilitating, costly and current approaches have limited success in alleviating suffering. The controlled delivery of biological molecules, such as growth factors (GFs) – proteins that orchestrate our